Iron deficiency in patients with myocardial infarction is associated with worse prognosis, reduced quality of life, lower physical capacity, and higher rehospitalization rates.
Does iron deficiency worsen prognosis and clinical outcomes in patients with acute myocardial infarction?
Iron deficiency is associated with worse prognosis, lower quality of life, and higher rehospitalization rates in patients with acute myocardial infarction, suggesting a potential benefit for iron supplementation.
Acute coronary syndromes (ACS) are a leading cause of death and impairment in the adult population. Precise identification and modification of risk factors is crucial for a favorable clinical outcome. In this review, we aim to provide a comprehensive overview of the significance of iron deficiency (ID) in patients with ACS, particularly myocardial infarction (MI). The paper evaluates the impact of ID on the prognosis of ACS patients, highlighting its potential influence on myocardial healing, regeneration and cardiovascular events during the follow-up period. The findings suggest that iron deficiency may have a negative impact on the prognosis of patients with MI, resulting in worse quality of life, physical capacity and higher rehospitalization rates in comparison to patients with normal iron status. Iron supplementation in patients with MI could be beneficial and may have an effect on myocardial healing and left ventricular remodeling.
Misiewicz et al. (Fri,) conducted a review in Acute Myocardial Infarction. Iron deficiency vs. Normal iron status was evaluated on Prognosis, quality of life, physical capacity, and rehospitalization rates. Iron deficiency in patients with myocardial infarction is associated with worse prognosis, reduced quality of life, lower physical capacity, and higher rehospitalization rates.